NEW YORK (GenomeWeb News) — Miraculins said yesterday it has pocketed CA$428,000 ($405,000) in a private stock placement by selling 1,222,858 units of certain shares at CA$.35 apiece.
 
The company said in July it could earn as much as CA$500,000 total from the sale by selling 1.25 million units at CA$.40 apiece.
 
Miraculins plans to use the money to fund research and development projects and to replenish working capital coffers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.